• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Sulfonylurea-responsive neonatal diabetes mellitus diagnosed through molecular genetics in two children and in one adult after a long period of insulin treatment.

作者信息

Fanciullo Lavinia, Iovane Brunella, Gkliati Dimitra, Monti Giorgia, Sponzilli Ivonne, Cangelosi Antonina Marta, Matrorilli Carla, Chiari Giovanni, Barbetti Fabrizio, Dall'Aglio Elisabetta, Vanelli Maurizio

机构信息

Postgraduate School of Pediatrics, University of Parma, Parma, Italy.

出版信息

Acta Biomed. 2012 Apr;83(1):56-61.

PMID:22978060
Abstract

A permanent neonatal diabetes mellitus has finally been diagnosed through molecular genetics in two children and one adult after 9 to 35 years of uninterrupted insulin treatment. These patients developed diabetes before 6 months of age and were autoantibody negative. In one boy, a mutation in the KCNJ11 gene was identified at 9 years of age. In the other two patients (daughter and father, 12.6 and 25 years old respectively) the new gene variant (ABCC8/L213P) was found. Switching from insulin to sulfonylurea treatment leads to the definitive discontinuance of insulin therapy, improving metabolic control as well as the amelioration of the associated neurodevelopmental disabilities in the young girl in which an intermediate Development Delay, Epilepsy, Neonatal Diabetes syndrome was diagnosed.

摘要

相似文献

1
Sulfonylurea-responsive neonatal diabetes mellitus diagnosed through molecular genetics in two children and in one adult after a long period of insulin treatment.
Acta Biomed. 2012 Apr;83(1):56-61.
2
Sulfonylurea-responsive diabetes in childhood.儿童磺脲类药物反应性糖尿病
J Pediatr. 2007 May;150(5):553-5. doi: 10.1016/j.jpeds.2007.03.004.
3
Transfer to sulphonylurea therapy in adult subjects with permanent neonatal diabetes due to KCNJ11-activating [corrected] mutations: evidence for improvement in insulin sensitivity.对于因KCNJ11激活[校正后]突变导致永久性新生儿糖尿病的成年患者,转换为磺脲类药物治疗:胰岛素敏感性改善的证据。
Diabetes Care. 2007 Jan;30(1):147-9. doi: 10.2337/dc06-1628.
4
Successful sulfonylurea treatment of a neonate with neonatal diabetes mellitus due to a new KCNJ11 mutation.成功用磺酰脲类药物治疗因 KCNJ11 新突变导致的新生儿糖尿病的新生儿。
Diabetes Res Clin Pract. 2011 Jan;91(1):e1-3. doi: 10.1016/j.diabres.2010.09.027. Epub 2010 Nov 5.
5
Permanent neonatal diabetes mellitus caused by a novel mutation in the KCNJ11 gene.由KCNJ11基因新突变引起的永久性新生儿糖尿病。
J Pediatr Endocrinol Metab. 2014 Mar;27(3-4):367-71. doi: 10.1515/jpem-2013-0068.
6
[Neonatal diabetes mellitus].[新生儿糖尿病]
Duodecim. 2011;127(6):534-41.
7
Successful transfer from insulin to oral sulfonylurea in a 3-year-old girl with a mutation in the KCNJ11 gene.一名患有KCNJ11基因突变的3岁女孩成功从胰岛素转换为口服磺脲类药物治疗。
Ann Saudi Med. 2010 Mar-Apr;30(2):162-4. doi: 10.4103/0256-4947.60526.
8
Outpatient transition of an infant with permanent neonatal diabetes due to a KCNJ11 activating mutation from subcutaneous insulin to oral glyburide.一名因KCNJ11激活突变导致永久性新生儿糖尿病的婴儿从皮下注射胰岛素转换为口服格列本脲的门诊过渡治疗。
Pediatr Diabetes. 2008 Jun;9(3 Pt 1):236-9. doi: 10.1111/j.1399-5448.2007.00316.x. Epub 2008 Jan 24.
9
Sulfonylurea improves CNS function in a case of intermediate DEND syndrome caused by a mutation in KCNJ11.在一例由KCNJ11突变引起的中间型DEND综合征病例中,磺脲类药物改善了中枢神经系统功能。
Nat Clin Pract Neurol. 2007 Nov;3(11):640-5. doi: 10.1038/ncpneuro0640.
10
Diabetes and hypoglycaemia in young children and mutations in the Kir6.2 subunit of the potassium channel: therapeutic consequences.幼儿糖尿病与低血糖以及钾通道Kir6.2亚基突变:治疗后果
Diabetes Metab. 2006 Dec;32(6):569-80. doi: 10.1016/S1262-3636(07)70311-7.

引用本文的文献

1
Clinical and Genetic Characteristics of Nonneonatal Diabetes Mellitus: A Systematic Review.非新生儿糖尿病的临床和遗传特征:系统综述。
J Diabetes Res. 2021 Sep 30;2021:9479268. doi: 10.1155/2021/9479268. eCollection 2021.
2
New insights into K channel gene mutations and neonatal diabetes mellitus.钾通道基因突变与新生儿糖尿病的新见解。
Nat Rev Endocrinol. 2020 Jul;16(7):378-393. doi: 10.1038/s41574-020-0351-y. Epub 2020 May 6.
3
A case with relapsed transient neonatal diabetes mellitus treated with sulfonylurea, ending chronic insulin requirement.
一例复发性短暂性新生儿糖尿病患者,使用磺脲类药物治疗,最终不再需要长期胰岛素治疗。
Endocrinol Diabetes Metab Case Rep. 2018 Apr 11;2018. doi: 10.1530/EDM-18-0005. eCollection 2018.
4
ABCC8-Related Maturity-Onset Diabetes of the Young (MODY12): Clinical Features and Treatment Perspective.ABCC8相关的青年发病型糖尿病(MODY12):临床特征与治疗前景
Diabetes Ther. 2016 Sep;7(3):591-600. doi: 10.1007/s13300-016-0192-9. Epub 2016 Aug 18.
5
A 'picturesque' case of transition from subcutaneous to oral treatment in neonatal diabetes.
BMJ Case Rep. 2014 May 14;2014:bcr2013202912. doi: 10.1136/bcr-2013-202912.